MyCAFs tend to be enriched amongst the most tumor adjacent fibroblasts where tumor secreted factors such as TGF-β, and microenvironmental cues such as increased tissue stiffness, drive and sustain the phenotype (Avery et al., 2018; Midgley et al., 2013). The gene discussed is TGFB1; the disease is neoplasm.